Related Experiment Videos
Discovery of cytokine mimics using cell-based systems
1Depatment of New Leads Discovery Ligand Pharmaceuticals 10275 Science Center Drive, CA 92121, San Diego, USA
Drug Discovery Today
|September 21, 2001
Summary
Discovering small-molecule mimics for cytokine and growth factor receptors is challenging. Recent advances in cell-based assays are enabling high-throughput screening (HTS) for novel therapeutic agonists.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Recombinant cytokines and growth factors are established therapeutics.
- Identifying small-molecule agonists for cytokine/growth factor receptors is difficult compared to G-protein-coupled receptors.
- Recent reports show the first small peptide and non-peptidic agonists for these receptors.
Purpose of the Study:
- To review cell-based assay technologies for high-throughput screening (HTS).
- To highlight applications in discovering novel cytokine and growth factor mimics.
- To address the challenge of finding small-molecule agonists for these receptor families.
Main Methods:
- Review of recent cell-based assay technologies.
- Focus on assays suitable for high-throughput screening (HTS).
- Analysis of methods used for identifying and characterizing receptor agonists.
Main Results:
- Small peptides and non-peptidic small-molecule agonists have been identified for several receptors.
- Cell-based functional assays are crucial for initial identification and characterization.
- Emerging assay technologies facilitate HTS for these mimics.
Conclusions:
- Cell-based assays are essential for discovering small-molecule cytokine and growth factor mimics.
- Advancements in HTS assay technologies are accelerating the discovery process.
- This approach holds promise for developing novel therapeutics targeting these receptor families.